title: Letter by Sardar et al regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial".
authors.affiliation: Department of Cardiology, Texas Tech University Health Sciences Center, El Paso, TX.
authors.forename: Partha
authors.initials: P
authors.lastname: Sardar
authors.affiliation: Department of Medicine, New York Medical College-Metropolitan Hospital Center, New York, NY.
authors.forename: Ramez
authors.initials: R
authors.lastname: Nairooz
authors.affiliation: Department of Medicine, New York Medical College-Metropolitan Hospital Center, New York, NY.
authors.forename: Gerald
authors.initials: G
authors.lastname: Pekler
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000188:drug therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D013988:Ticlopidine; D001241:Aspirin